Tobacco smoking

Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation

Retrieved on: 
Wednesday, June 29, 2022
Smoking, FDA, National, Adult, Research, National Institute, Degenerative disease, Brain, Trial of the century, GLOBE, Death, COVID-19, Goal, U.S. Securities and Exchange Commission, Smoker, Lung cancer, United, NIH, Risk, Food, Partnership, Moyamoya disease, Clinical trial, National Institute on Drug Abuse, Private Securities Litigation Reform Act, Nicotine, Transfusion-related acute lung injury, Nasdaq, Health, NIDA, Reward, List of life sciences, Regulation of tobacco by the U.S. Food and Drug Administration, Safety, Nature, Tobacco smoking, Intention, Security (finance), Pharmaceutical industry, Tobacco

During the first phase, Achieves Investigational New Drug application for nicotine e-cigarette cessation was reviewed and accepted by the U.S. Food and Drug Administration (FDA) late last year.

Key Points: 
  • During the first phase, Achieves Investigational New Drug application for nicotine e-cigarette cessation was reviewed and accepted by the U.S. Food and Drug Administration (FDA) late last year.
  • In addition to the initiated ORCA-V1 trial, Achieve is evaluating smoking cessation of combustible cigarettes in its Phase 3 clinical development program.
  • The ORCA-2 clinical trial, which was comprised of 810 adult smokers, announced positive topline results in April.
  • The ORCA-3 trial, the intended confirmatory Phase 3 trial required for regulatory submission of cytisinicline, is currently enrolling smokers at 15 clinical trial locations in the United States.

Mevol New Products Draw Massive Crowds at Dubai Vaping Expo!

Retrieved on: 
Thursday, June 23, 2022
Tobacco, Retail, Specialty, Other Retail, Smoker, Time, Industry, Gold, Smoking, Learning, Taste, Herbal cigarette, Health status of Asian Americans, Tobacco smoking, Color, Adult, Life, Silver, Multimedia, E 11 road (United Arab Emirates), Nightclub, Tobacco

The brand highlighted what is now possible in the space, giving punters a taste of the future of vaping.

Key Points: 
  • The brand highlighted what is now possible in the space, giving punters a taste of the future of vaping.
  • View the full release here: https://www.businesswire.com/news/home/20220621005589/en/
    Mevol New Products Draw Massive Crowds at Dubai Vaping Expo!
  • Alongside the Mevol X, Mevol also showcased the Mevol Bar.
  • For those interested in learning more about Mevol and its innovative products, please visit www.mevol.com .

The Worldwide Electrophysiology Industry is Expected to Reach $11.9 Billion by 2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 21, 2022
Health, Medical Devices, Cardiology, CAGR, Population, Stryker, Union, WHO, Atrial flutter, Budget, World, CE marking, Risk, Smartphone, Dyslipidemia, Hospital, USD, Disease, Hypertension, Stroke, EP, World Health Organization, Incidence, AED, Prevalence, Heart, Canadian International Council, CVD, Death, Person, American Heart Association, Heart failure, Suds, WPW, Pandemic, Ban on caffeinated alcoholic drinks, Industry, FDA, Abbott Laboratories, Atrial fibrillation, Electrophysiology, Adoption, AVNRT, Catheter, Laboratory, Diagnosis, Medical tourism, Diabetes, US Foods, Mortality, Obesity, Cardiovascular disease, Arrhythmia, ICE, ICM, Tobacco smoking, Food, Product life-cycle theory, ICDS, Awareness, Liquor, Medical device, Pharmaceutical industry, Recycling, Implantable cardioverter-defibrillator

The Global Electrophysiology Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.

Key Points: 
  • The Global Electrophysiology Market size is expected to reach $11.9 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.
  • Electrophysiology (EP) devices are a type of medical equipment that is used to diagnose and treat cardiovascular problems.
  • In the event of an emergency, these devices send & receive electrical signals to & from the heart to regulate the heartbeat.
  • According to the WHO organization, CVD expenses is expected to reach USD 1,044 billion by 2030, up from USD 863 billion in 2010.

Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference

Retrieved on: 
Tuesday, June 21, 2022
Smoker, Security (finance), FDA, Smoking, COVID-19, Degenerative disease, Safety, Death, Research, Tobacco smoking, Brain, U.S. Securities and Exchange Commission, Risk, Private Securities Litigation Reform Act, Moyamoya disease, Lotte New York Palace Hotel, Health, NASDAQ, Nature, Lung cancer, Food, Nicotine, Conference, Regulation of tobacco by the U.S. Food and Drug Administration, Reward, GLOBE, Goal, Transfusion-related acute lung injury, Tobacco

Details to access the presentation are as follows:

Key Points: 
  • Details to access the presentation are as follows:
    To register for the conference, click HERE .
  • Achieves focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.
  • All statements other than statements of historical fact are statements that could be deemed forward-looking statements.
  • Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable.

Canadian Cancer Society commends world-first requirement for health warnings on every cigarette

Retrieved on: 
Friday, June 10, 2022
Leadership, Human, Canadian Cancer Society, Smoke, Tobacco smoking, WHO Framework Convention on Tobacco Control, Smoker, Government, Awareness, Smoking, Sale, CCS, Population, Death, Cancer, Tobacco, Stomach cancer, Oil

OTTAWA, ON, June 10, 2022 /CNW/ - The Canadian Cancer Society (CCS) today praised proposed federal regulations to require a health warning directly on every cigarette, a world first.

Key Points: 
  • OTTAWA, ON, June 10, 2022 /CNW/ - The Canadian Cancer Society (CCS) today praised proposed federal regulations to require a health warning directly on every cigarette, a world first.
  • Warnings on the cigarette itself will impact youth who may experiment by "borrowing" cigarettes from a friend or sibling.
  • CCS has long advocated for health warnings to appear on each cigarette and applauds the world leadership being demonstrated by the Canadian government.
  • There are now more than 130 countries and territories that have implemented picture health warnings, following the Canadian precedent, as outlined in a 2021 Canadian Cancer Society report .

Non-invasive Ventilators: A Review of Global Markets 2019-2021 with Forecasts to 2026, Featuring Profiles of Major Players Including GE, Hamilton Medical, and Smiths Medical - ResearchAndMarkets.com

Retrieved on: 
Friday, June 3, 2022
Medical Devices, Health, Exercise, Epidemiology, GE, Company, Medical tourism, Degenerative disease, Environment, Medtech, Disease, Coronavirus, Growth, Tobacco smoking, COVID-19, Pandemic, Prevalence, Industry, Urbanization, Pharmaceutical industry, Risk management

Also, pandemics like the 2019 Novel Coronavirus (COVID-19) drive the global demand for non-invasive ventilators.

Key Points: 
  • Also, pandemics like the 2019 Novel Coronavirus (COVID-19) drive the global demand for non-invasive ventilators.
  • It offers a detailed analysis of the competitive environment, regulatory scenario, technological advancement, drivers and restraints, and opportunities and trends in market growth.
  • The report also covers market projections to 2026 and market rank for key market players.
  • This report segments the global market by these geographical regions: North America, Europe, Asia-Pacific, and the Rest of the World.

Mevol Debuts the World's Slimmest Ceramic Coil Vape Product, Equipped with the New FEELM Air

Retrieved on: 
Friday, May 27, 2022
Internet, Senior, AIR, University, Goal, Gold, Smoker, Health, Tobacco smoking, Color, Adult, Research, Silver, Graphite, Awareness, Inhalation, Technology, Safety, Taste, Quality control, Exhibition, Exhalation, Video game, Video game console, Tobacco

Emerging vaping brand, Mevol, is introducing two new devices, the Mevol X and Mevol Bar, improving the vaping experience for its customers across the globe.

Key Points: 
  • The new Mevol X offers a "slimmer and smoother" 8mm vape body with a metallic exterior.
  • "Encased in metal with a minimalistic slim design," the Mevol X offers superior grip and is both "lightweight and portable."
  • The new ultra-slim comes with the latest generation of the FEELM AIR ceramic coil, comprising 7-layer composite film ceramic coil, microporous bionic structure and nanoscale vacuumed film-forming.
  • It is equipped with a FEELM ceramic coil, which provides smooth, stable, and silent transmission of vape particles.

Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation

Retrieved on: 
Thursday, May 5, 2022
Ethinylestradiol, Birth, CHC, LNG, Population, Nasdaq, Woman, GLOBE, ACOG, Company, Securities Exchange Act of 1934, Securities Act of 1933, Food, Safety, Smoke, Poster, United, Patient, Doctor of Philosophy, Șaeș, Clinical trial, Risk, Freedom, Annual report, Drug Quality and Security Act, Regulation of tobacco by the U.S. Food and Drug Administration, BMI, Prescription, FACOG, Kro (comics), Skin, Health, Levonorgestrel, TDS, MBA, Tobacco smoking, HCPS, U.S. Securities and Exchange Commission, Body mass index, Doctor of Pharmacy, Therapy, Medical device, Birth control, MD, Contraceptive patch

No venous thromboembolic events (VTEs) were reported, and two serious adverse events (SAEs) were reported, findings which are consistent with the safety profile reported in the SECURE study.

Key Points: 
  • No venous thromboembolic events (VTEs) were reported, and two serious adverse events (SAEs) were reported, findings which are consistent with the safety profile reported in the SECURE study.
  • These data from real-world use among a diverse US population further support the Twirla safety and tolerability profile established in the SECURE clinical trial, said Paul Korner, MD, MBA, Chief Medical Officer of Agile Therapeutics.
  • In addition to the safety findings, reports of TDS adhesion issues were rare, and only 14 individuals received a replacement patch over the 12-month period.
  • For all these reasons, actual results and developments could be materially different from those expressed in or implied by our forward-looking statements.

FDA's Proposed Rules to Prohibit Menthol Cigarettes and Flavored Cigars Will Protect Kids, Advance Health Equity and Save Lives, Especially Among Black Americans

Retrieved on: 
Thursday, April 28, 2022
Congressional Black Caucus, Tobacco industry, Smoke, Social policy of the Joe Biden administration, Sale, Tobacco Products Scientific Advisory Committee, Public health, Education, FDA, Stroke, Chocolate, Smokeless tobacco, Organization, Cancer, Tobacco smoking, Marketing, Failure, Congressional Black Caucus Foundation, Health equity, Smoking, Research, African Americans, NAACP, Menthol, Congress, Degenerative disease, Industry, Tobacco, Population, COVID-19, Health, Smoker, Black

WASHINGTON, April 28, 2022 /PRNewswire/ -- By issuing proposed rules today to prohibit menthol cigarettes and all flavored cigars, the FDA is taking historic and long-overdue action to protect our nation's kids, advance health equity and save lives, especially among Black Americans and other populations that have been targeted by the tobacco industry and suffered enormous harm from the predatory marketing of these products.  For decades the tobacco industry has deliberately targeted Black communities with marketing for menthol cigarettes, with tragic consequences. The industry also uses these flavored products to lure kids into a deadly addiction. These rules will, once and for all, put an end to these predatory and deadly practices. 

Key Points: 
  • For decades the tobacco industry has deliberately targeted Black communities with marketing for menthol cigarettes, with tragic consequences.
  • The FDA's proposal to ban menthol cigarettes and flavored cigars will have a profound and certain impact in reducing these health disparities.
  • Eliminating menthol cigarettes will save lives and reduce health disparities, especially among Black Americans.
  • The industry's targeted marketing of menthol cigarettes has caused enormous harm to the health of Black Americans.

Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z

Retrieved on: 
Thursday, March 31, 2022
Birth, Company, Risk, Therapy, Human, Marketing, Friends, Skin, Ethinylestradiol, CTV, Gen, Woman, CHC, Body mass index, Health, Philosophy, BMI, Tobacco smoking, Industry, Securities Exchange Act of 1934, Securities Act of 1933, Nasdaq, U.S. Securities and Exchange Commission, GLOBE, Generation Z, Smoke, HCPS, Freedom, Female, LNG, Awareness, Annual report, Levonorgestrel, Birth control, Entertainment, Music, Contraceptive patch

PRINCETON, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the launch of its first consumer commercial intended to increase awareness of the Twirla weekly birth control patch.

Key Points: 
  • The commercial highlights consumer attitudes that may lead to interest in using Twirla for birth control, telling a story about reproductive health choices through a playful and realistic lens.
  • Our Gen Z target appreciates transparency and authenticity, said Amy Welsh, vice president of marketing for Agile Therapeutics.
  • When we saw Mayas previous work and learned more about her philosophy for reaching Gen Z through believable character development, we knew she would be the right fit for us.
  • She helped us cast a diverse set of Gen Z actors who feel like real women on screen.